Physicochemical Properties
| Molecular Formula | C32H16CON8 |
| Molecular Weight | 573.47212 |
| Exact Mass | 514.165 |
| CAS # | 3317-67-7 |
| Related CAS # | 36344-62-4 |
| PubChem CID | 76829 |
| Appearance | Pale purple to purple solid powder |
| Density | 1.6±0.1 g/cm3 |
| Melting Point | 300 °C |
| Index of Refraction | 1.891 |
| LogP | 4.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 0 |
| Heavy Atom Count | 41 |
| Complexity | 709 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | MPMSMUBQXQALQI-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C32H16N8.Co/c1-2-10-18-17(9-1)25-33-26(18)38-28-21-13-5-6-14-22(21)30(35-28)40-32-24-16-8-7-15-23(24)31(36-32)39-29-20-12-4-3-11-19(20)27(34-29)37-25;/h1-16H;/q-2;+2 |
| Chemical Name | cobalt(2+);2,11,20,29,37,39-hexaza-38,40-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3,5,7,9,11,13,15,17,19(39),20,22,24,26,28,30(37),31,33,35-nonadecaene |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: (1). This product requires protection from light (avoid light exposure) during transportation and storage.(2). Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Cobalt(II) phthalocyanine catalyzed aerobic regeneration of carbonyl compounds from the corresponding oximes in 1-butyl-3-methylimidazolium bromide. Applied Catalysis A: General. 2009 Dec, 371(1-2): 148-152. [2]. The use of copper and cobalt phthalocyanines as electrocatalysts for the oxygen reduction reaction in acid medium. Electrochimica Acta, 2014, 139: 1-6. |
| Additional Infomation |
- Cobalt phthalocyanine is a synthetic metal phthalocyanine compound primarily used as a chemical catalyst [1][2] - In catalytic chemistry, it exhibits efficient catalytic activity for the aerobic regeneration of carbonyl compounds from oximes. In 1-butyl-3-methylimidazolium bromide (ionic liquid) as the solvent, Cobalt phthalocyanine (catalyst loading: 2 mol%) catalyzed the reaction at 80°C under atmospheric oxygen. It achieved high conversion rates (85-98%) for various aromatic and aliphatic oximes, with excellent selectivity for corresponding aldehydes or ketones (gas chromatography-mass spectrometry, GC-MS analysis) [1] - It acts as an electrocatalyst for the oxygen reduction reaction (ORR) in acid medium. Modified on a glassy carbon electrode, Cobalt phthalocyanine showed good electrocatalytic performance: onset potential of ~0.85 V (vs. reversible hydrogen electrode, RHE), high current density, and stable catalytic activity over continuous cycling. It followed a four-electron transfer pathway for ORR, with low peroxide yield (rotating ring-disk electrode, RRDE measurement) [2] |
Solubility Data
| Solubility (In Vitro) | May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples |
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples. Injection Formulations (e.g. IP/IV/IM/SC) Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] *Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin → 500 μL Saline) Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO → 100 μLPEG300 → 200 μL castor oil → 650 μL Saline) Injection Formulation 7: Ethanol : Cremophor : Saline = 10： 10 : 80 (i.e. 100 μL Ethanol → 100 μL Cremophor → 800 μL Saline) Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH → 900 μL Corn oil) Injection Formulation 10: EtOH : PEG300：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Oral Formulations Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). Oral Formulation 3: Dissolved in PEG400 Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose Oral Formulation 6: Mixing with food powders Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.7438 mL | 8.7189 mL | 17.4377 mL | |
| 5 mM | 0.3488 mL | 1.7438 mL | 3.4875 mL | |
| 10 mM | 0.1744 mL | 0.8719 mL | 1.7438 mL |